Terms: = Prostate cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Prognosis
42 results:
1. Risk of Biochemical Recurrence in Patients With Grade Group 1 prostate cancer With Extraprostatic Extension Treated With Radical prostatectomy.
Rezaee ME; Pallauf M; Fletcher SA; Han M; Pavlovich CP; Cornelia Ding CK; Epstein JI; Allaf ME; Trock BJ; Singla N
J Urol; 2024 Mar; 211(3):407-414. PubMed ID: 38109699
[TBL] [Abstract] [Full Text] [Related]
2. Aspartoacylase suppresses prostate cancer progression by blocking LYN activation.
Weng H; Xiong KP; Wang W; Qian KY; Yuan S; Wang G; Yu F; Luo J; Lu MX; Yang ZH; Liu T; Huang X; Zheng H; Wang XH
Mil Med Res; 2023 Jun; 10(1):25. PubMed ID: 37271807
[TBL] [Abstract] [Full Text] [Related]
3. Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol.
Siltari A; Riikonen J; Koskimäki J; Pakarainen T; Ettala O; Boström P; Seikkula H; Kotsar A; Tammela T; Helminen M; Raittinen PV; Lehtimäki T; Fode M; Østergren P; Borre M; Rannikko A; Marttila T; Salonen A; Ronkainen H; Löffeler S; Murtola TJ
BMJ Open; 2022 Apr; 12(4):e050264. PubMed ID: 35487730
[TBL] [Abstract] [Full Text] [Related]
4. Quality Assessment of Online Resources for the Most Common cancers.
Li JZH; Kong T; Killow V; Wang L; Kobes K; Tekian A; Ingledew PA
J Cancer Educ; 2023 Feb; 38(1):34-41. PubMed ID: 34365589
[TBL] [Abstract] [Full Text] [Related]
5. Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial.
Sweeney C; Bracarda S; Sternberg CN; Chi KN; Olmos D; Sandhu S; Massard C; Matsubara N; Alekseev B; Parnis F; Atduev V; Buchschacher GL; Gafanov R; Corrales L; Borre M; Stroyakovskiy D; Alves GV; Bournakis E; Puente J; Harle-Yge ML; Gallo J; Chen G; Hanover J; Wongchenko MJ; Garcia J; de Bono JS
Lancet; 2021 Jul; 398(10295):131-142. PubMed ID: 34246347
[TBL] [Abstract] [Full Text] [Related]
6. Au-Ag assembled on silica nanoprobes for visual semiquantitative detection of prostate-specific antigen.
Kim HM; Kim J; An J; Bock S; Pham XH; Huynh KH; Choi Y; Hahm E; Song H; Kim JW; Rho WY; Jeong DH; Lee HY; Lee S; Jun BH
J Nanobiotechnology; 2021 Mar; 19(1):73. PubMed ID: 33712008
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic impact of prior local therapy in castration-resistant prostate cancer.
Koura M; Shiota M; Ueda S; Matsumoto T; Kobayashi S; Monji K; Kashiwagi E; Takeuchi A; Inokuchi J; Shiga KI; Yokomizo A; Eto M
Jpn J Clin Oncol; 2021 Jul; 51(7):1142-1148. PubMed ID: 33621330
[TBL] [Abstract] [Full Text] [Related]
8. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
[TBL] [Abstract] [Full Text] [Related]
9. Morbidity, perioperative outcomes and complications of robot-assisted radical prostatectomy in kidney transplant patients: A French multicentre study.
Felber M; Drouin SJ; Grande P; Vaessen C; Parra J; Barrou B; Matillon X; Crouzet S; Leclerc Q; Rigaud J; Prudhomme T; Doumerc N; Bergerat S; Lang H; Laine C; Robert G; Gobert A; Granger B; Rouprêt M
Urol Oncol; 2020 Jun; 38(6):599.e15-599.e21. PubMed ID: 31948931
[TBL] [Abstract] [Full Text] [Related]
10. Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate.
Borkowetz A; Froehner M; Rauner M; Conrad S; Erdmann K; Mayr T; Datta K; Hofbauer LC; Baretton GB; Wirth M; Fuessel S; Toma M; Muders MH
Int J Cancer; 2020 May; 146(9):2619-2627. PubMed ID: 31509606
[TBL] [Abstract] [Full Text] [Related]
11. Management of positive lymph nodes following radical prostatectomy.
Heidenreich A; Rieke M; Mahjoub S; Pfister D
Arch Esp Urol; 2019 Mar; 72(2):182-191. PubMed ID: 30855020
[TBL] [Abstract] [Full Text] [Related]
12. PET imaging in renal cancer.
Lindenberg L; Mena E; Choyke PL; Bouchelouche K
Curr Opin Oncol; 2019 May; 31(3):216-221. PubMed ID: 30747736
[TBL] [Abstract] [Full Text] [Related]
13. Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic prostate cancer with and without PTEN Loss.
de Bono JS; De Giorgi U; Rodrigues DN; Massard C; Bracarda S; Font A; Arranz Arija JA; Shih KC; Radavoi GD; Xu N; Chan WY; Ma H; Gendreau S; Riisnaes R; Patel PH; Maslyar DJ; Jinga V
Clin Cancer Res; 2019 Feb; 25(3):928-936. PubMed ID: 30037818
[TBL] [Abstract] [Full Text] [Related]
14. A Temporal Examination of Platelet Counts as a Predictor of prognosis in Lung, prostate, and Colon cancer Patients.
Sylman JL; Boyce HB; Mitrugno A; Tormoen GW; Thomas IC; Wagner TH; Lee JS; Leppert JT; McCarty OJT; Mallick P
Sci Rep; 2018 Apr; 8(1):6564. PubMed ID: 29700384
[TBL] [Abstract] [Full Text] [Related]
15. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer.
Burdelski C; Borcherding L; Kluth M; Hube-Magg C; Melling N; Simon R; Möller-Koop C; Weigand P; Minner S; Haese A; Michl HU; Tsourlakis MC; Jacobsen F; Hinsch A; Wittmer C; Lebok P; Steurer S; Izbicki JR; Sauter G; Krech T; Büscheck F; Clauditz T; Schlomm T; Wilczak W
Oncotarget; 2017 May; 8(19):31494-31508. PubMed ID: 28415558
[TBL] [Abstract] [Full Text] [Related]
16. Fruit and vegetables consumption is directly associated to survival after prostate cancer.
Taborelli M; Polesel J; Parpinel M; Stocco C; Birri S; Serraino D; Zucchetto A
Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27805317
[TBL] [Abstract] [Full Text] [Related]
17. p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.
Burdelski C; Dieckmann T; Heumann A; Hube-Magg C; Kluth M; Beyer B; Steuber T; Pompe R; Graefen M; Simon R; Minner S; Tsourlakis MC; Koop C; Izbicki J; Sauter G; Krech T; Schlomm T; Wilczak W; Lebok P
Tumour Biol; 2016 Sep; 37(9):12655-12663. PubMed ID: 27444279
[TBL] [Abstract] [Full Text] [Related]
18. Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation.
Hwa YL; Shi Q; Kumar SK; Lacy MQ; Gertz MA; Kapoor P; Buadi FK; Leung N; Dingli D; Go RS; Hayman SR; Gonsalves WI; Russell S; Lust JA; Lin Y; Rajkumar SV; Dispenzieri A
Am J Hematol; 2017 Jan; 92(1):50-55. PubMed ID: 27733010
[TBL] [Abstract] [Full Text] [Related]
19. Role of salvage lymph node dissection in prostate cancer.
Heidenreich A; Moul JW; Shariat S; Karnes RJ
Curr Opin Urol; 2016 Nov; 26(6):581-9. PubMed ID: 27584024
[TBL] [Abstract] [Full Text] [Related]
20. First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry.
Droz JP; Efstathiou E; Yildirim A; Cabrera P; Soo Kim C; Horchani A; Heidenreich A; Rinck-Junior JA; Hitier S; Ӧzen H
Urol Oncol; 2016 May; 34(5):234.e21-9. PubMed ID: 26777260
[TBL] [Abstract] [Full Text] [Related]
[Next]
